Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 245

1.

Metachronous adenocarcinoma of the remnant oesophagus 15 years following multimodal therapy.

Croghan S, McCormack O, Muldoon C, Ravi N, Reynolds JV.

Ir Med J. 2015 Jan;108(1):22-3.

PMID:
25702351
2.

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG).

Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, DʼJourno XB, Griffin SM, Hölscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ.

Ann Surg. 2015 Jan 20. [Epub ahead of print]

PMID:
25607756
3.

Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinoma.

Abdel-Latif MM, Kelleher D, Reynolds JV.

Eur J Cancer. 2015 Mar;51(4):464-72. doi: 10.1016/j.ejca.2014.11.014. Epub 2015 Jan 14.

PMID:
25596807
4.

Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma.

Lynam-Lennon N, Connaughton R, Carr E, Mongan AM, O'Farrell NJ, Porter RK, Brennan L, Pidgeon GP, Lysaght J, Reynolds JV, O'Sullivan J.

BMC Cancer. 2014 Dec 3;14:907. doi: 10.1186/1471-2407-14-907.

5.

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.

Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Moayyedi P, Watson P, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J.

Gastroenterology. 2015 Feb;148(2):367-78. doi: 10.1053/j.gastro.2014.10.041. Epub 2014 Nov 5.

6.

New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes.

Mc Cormack O, Zaborowski A, King S, Healy L, Daly C, OʼFarrell N, Donohoe CL, Ravi N, Reynolds JV.

Ann Surg. 2014 Nov;260(5):772-8; discussion 778. doi: 10.1097/SLA.0000000000000960.

PMID:
25379848
7.

Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.

Elliott JA, O'Farrell NJ, King S, Halpenny D, Malik V, Muldoon C, Johnston C, Reynolds JV.

Br J Surg. 2014 Dec;101(13):1702-11. doi: 10.1002/bjs.9670. Epub 2014 Oct 28.

PMID:
25351460
8.

Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus.

Phelan JJ, MacCarthy F, Feighery R, O'Farrell NJ, Lynam-Lennon N, Doyle B, O'Toole D, Ravi N, Reynolds JV, O'Sullivan J.

Cancer Lett. 2014 Nov 1;354(1):122-31. doi: 10.1016/j.canlet.2014.07.035. Epub 2014 Aug 10.

PMID:
25107643
9.

Images in clinical medicine. Intermittent facial flushing and diarrhea.

Mc Cormack O, Reynolds JV.

N Engl J Med. 2014 Jul 17;371(3):260. doi: 10.1056/NEJMicm1314969. No abstract available.

10.

Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma.

Lynam-Lennon N, Maher SG, Maguire A, Phelan J, Muldoon C, Reynolds JV, O'Sullivan J.

PLoS One. 2014 Jun 26;9(6):e100738. doi: 10.1371/journal.pone.0100738. eCollection 2014.

11.

Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery.

Mongan AM, Kalachand R, King S, O'Farrell NJ, Power D, Ravi N, Muldoon C, O'Byrne K, Reynolds JV.

Ir J Med Sci. 2015 Jun;184(2):417-23. doi: 10.1007/s11845-014-1135-y. Epub 2014 May 31.

PMID:
24879337
12.

The role of inflammation in cancer of the esophagus.

O'Sullivan KE, Phelan JJ, O'Hanlon C, Lysaght J, O'Sullivan JN, Reynolds JV.

Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):749-60. doi: 10.1586/17474124.2014.913478. Epub 2014 May 23. Review.

PMID:
24857183
13.

Oesophageal manometry: 10-year audit from a specialist centre, and early experience with high-resolution manometry.

Moran T, Lawlor P, Brennan M, Ravi N, Reynolds JV.

Ir J Med Sci. 2015 Jun;184(2):379-87. doi: 10.1007/s11845-014-1123-2. Epub 2014 May 10.

PMID:
24816461
14.

Preoperative inspiratory muscle training to prevent postoperative pulmonary complications in patients undergoing esophageal resection (PREPARE study): study protocol for a randomized controlled trial.

Valkenet K, Trappenburg JC, Gosselink R, Sosef MN, Willms J, Rosman C, Pieters H, Scheepers JJ, de Heus SC, Reynolds JV, Guinan E, Ruurda JP, Rodrigo EH, Nafteux P, Fontaine M, Kouwenhoven EA, Kerkemeyer M, van der Peet DL, Hania SW, van Hillegersberg R, Backx FJ.

Trials. 2014 Apr 27;15:144. doi: 10.1186/1745-6215-15-144.

15.

Leptin and adiponectin receptor expression in oesophageal cancer.

Howard JM, Cathcart MC, Healy L, Beddy P, Muldoon C, Pidgeon GP, Reynolds JV.

Br J Surg. 2014 May;101(6):643-52. doi: 10.1002/bjs.9469. Epub 2014 Mar 24.

PMID:
24664553
16.

Eosinophilic ascites with marked peripheral eosinophilia: a diagnostic challenge.

Elliott JA, McCormack O, Tchrakian N, Conlon N, Ryan CE, Lim KT, Ullah N, Mahmud N, Ravi N, McKiernan S, Feighery C, Reynolds JV.

Eur J Gastroenterol Hepatol. 2014 Apr;26(4):478-84. doi: 10.1097/MEG.0000000000000037.

PMID:
24535594
17.

Identification of potential therapeutic molecular targets preferentially expressed by esophageal cancer cells.

Nur MM, Finn S, Reynolds JV.

Expert Rev Anticancer Ther. 2014 Mar;14(3):267-9. doi: 10.1586/14737140.2014.889790. Epub 2014 Feb 12.

PMID:
24521391
18.

A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

Picardo SL, O'Brien MP, Feighery R, O'Toole D, Ravi N, O'Farrell NJ, O'Sullivan JN, Reynolds JV.

Dis Esophagus. 2015 Feb-Mar;28(2):121-6. doi: 10.1111/dote.12166. Epub 2014 Jan 15.

PMID:
24428806
19.

Management of maple syrup urine disease in the peri-operative period.

McCarron E, McCormack O, Cronin T, McGowan A, Healy ML, O'Rourke D, Crushell E, Ravi N, Reynolds JV.

Ir Med J. 2013 Oct;106(9):277-8.

PMID:
24416851
20.

The role of obesity in gastrointestinal cancer: evidence and opinion.

Donohoe CL, O'Farrell NJ, Doyle SL, Reynolds JV.

Therap Adv Gastroenterol. 2014 Jan;7(1):38-50. doi: 10.1177/1756283X13501786. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk